Managing incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategy

Background and study aims: Current guidelines recommend using endoscopic ultrasound (EUS), carcinoembryonic antigen (CEA) testing and cytology to manage incidental pancreatic cystic neoplasms (PCN); however, studies suggest a strategy including integrated molecular pathology (IMP) of cyst fluid may...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Ananya, Brugge, William, Mishra, Girish, Smith, Dennis M., Sachdev, Mankanwal, Ellsworth, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: © Georg Thieme Verlag KG 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612224/
https://www.ncbi.nlm.nih.gov/pubmed/26528505
http://dx.doi.org/10.1055/s-0034-1392016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612224/
https://www.ncbi.nlm.nih.gov/pubmed/26528505
http://dx.doi.org/10.1055/s-0034-1392016

Ejemplares similares